• +91 96866 96505
  • OncoStem Diagnostics Pvt Ltd
Contact Us
background

Scientific Publications

58 Results Found.

Breast Cancer Research & Treatment

Scientific Publication by OncoStem

September, 2022

A comparative analysis of recurrence risk predictions in ER+/HER2−early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
View

South Asian Journal of Cancer

Scientific Publication by Renowned Oncologists Worldwide

August, 2022

Ashok Vaid et al: Robust Guidelines for the Management of HR+/HER2 EBC: Crucial Value of CanAssist Breast
View

Annals of Oncology - Abstract Book of ESMO Breast Cancer 2022

Scientific Publication by OncoStem

April, 2022

9P-Long term recurrence risk predictions by CanAssist Breast in a sub-cohort of TEAM
View

The Breast

Scientific Publication by OncoStem

February, 2022

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort
View

The Breast

Scientific Publication by OncoStem

October, 2021

The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
View

BMC Cancer Part of Springer Nature

Scientific Publication by OncoStem

February, 2021

Multi-country clinical validation of CanAssist Breast in Europe indicates robustness of the test
View

Cancer Medicine

Scientific Publication by OncoStem

October, 2020

Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
View